Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/26/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/26/20 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/22/20 | DEF 14A | Definitive proxy statements |
|
17 | |
| 06/19/20 | 8-K | Current report filing |
|
63 | |
| 06/08/20 | 4 | Statement of changes in beneficial ownership of securities |
|
3 | |
| 06/08/20 | PRER14A | Preliminary revised proxy soliciting materials |
|
18 | |
| 06/08/20 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
17 | |
| 06/02/20 | 8-K | Current report filing |
|
3 | |
| 06/02/20 | 8-K/A | Current report filing |
|
3 | |
| 05/15/20 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 |
